Cyclic Peptide Compounds- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global market for Cyclic Peptide Compounds was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cyclic Peptide Compounds include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Cyclic Peptide Compounds, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cyclic Peptide Compounds by region & country, by Type, and by Application.

The Cyclic Peptide Compounds market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclic Peptide Compounds.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cyclic Peptide Compounds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cyclic Peptide Compounds in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Cyclic Peptide Compounds Product Introduction
    1.2 Global Cyclic Peptide Compounds Market Size Forecast
        1.2.1 Global Cyclic Peptide Compounds Sales Value (2019-2030)
        1.2.2 Global Cyclic Peptide Compounds Sales Volume (2019-2030)
        1.2.3 Global Cyclic Peptide Compounds Sales Price (2019-2030)
    1.3 Cyclic Peptide Compounds Market Trends & Drivers
        1.3.1 Cyclic Peptide Compounds Industry Trends
        1.3.2 Cyclic Peptide Compounds Market Drivers & Opportunity
        1.3.3 Cyclic Peptide Compounds Market Challenges
        1.3.4 Cyclic Peptide Compounds Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Cyclic Peptide Compounds Players Revenue Ranking (2023)
    2.2 Global Cyclic Peptide Compounds Revenue by Company (2019-2024)
    2.3 Global Cyclic Peptide Compounds Players Sales Volume Ranking (2023)
    2.4 Global Cyclic Peptide Compounds Sales Volume by Company Players (2019-2024)
    2.5 Global Cyclic Peptide Compounds Average Price by Company (2019-2024)
    2.6 Key Manufacturers Cyclic Peptide Compounds Manufacturing Base and Headquarters
    2.7 Key Manufacturers Cyclic Peptide Compounds Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Cyclic Peptide Compounds
    2.9 Cyclic Peptide Compounds Market Competitive Analysis
        2.9.1 Cyclic Peptide Compounds Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Cyclic Peptide Compounds Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptide Compounds as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Natural Cyclic Peptide
        3.1.2 Synthetic Cyclic Peptide
    3.2 Global Cyclic Peptide Compounds Sales Value by Type
        3.2.1 Global Cyclic Peptide Compounds Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Cyclic Peptide Compounds Sales Value, by Type (2019-2030)
        3.2.3 Global Cyclic Peptide Compounds Sales Value, by Type (%) (2019-2030)
    3.3 Global Cyclic Peptide Compounds Sales Volume by Type
        3.3.1 Global Cyclic Peptide Compounds Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Cyclic Peptide Compounds Sales Volume, by Type (2019-2030)
        3.3.3 Global Cyclic Peptide Compounds Sales Volume, by Type (%) (2019-2030)
    3.4 Global Cyclic Peptide Compounds Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Biopharmaceutical
        4.1.2 Environmental Protection
        4.1.3 Scientific Research
        4.1.4 Others
    4.2 Global Cyclic Peptide Compounds Sales Value by Application
        4.2.1 Global Cyclic Peptide Compounds Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Cyclic Peptide Compounds Sales Value, by Application (2019-2030)
        4.2.3 Global Cyclic Peptide Compounds Sales Value, by Application (%) (2019-2030)
    4.3 Global Cyclic Peptide Compounds Sales Volume by Application
        4.3.1 Global Cyclic Peptide Compounds Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Cyclic Peptide Compounds Sales Volume, by Application (2019-2030)
        4.3.3 Global Cyclic Peptide Compounds Sales Volume, by Application (%) (2019-2030)
    4.4 Global Cyclic Peptide Compounds Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Cyclic Peptide Compounds Sales Value by Region
        5.1.1 Global Cyclic Peptide Compounds Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Cyclic Peptide Compounds Sales Value by Region (2019-2024)
        5.1.3 Global Cyclic Peptide Compounds Sales Value by Region (2025-2030)
        5.1.4 Global Cyclic Peptide Compounds Sales Value by Region (%), (2019-2030)
    5.2 Global Cyclic Peptide Compounds Sales Volume by Region
        5.2.1 Global Cyclic Peptide Compounds Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Cyclic Peptide Compounds Sales Volume by Region (2019-2024)
        5.2.3 Global Cyclic Peptide Compounds Sales Volume by Region (2025-2030)
        5.2.4 Global Cyclic Peptide Compounds Sales Volume by Region (%), (2019-2030)
    5.3 Global Cyclic Peptide Compounds Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Cyclic Peptide Compounds Sales Value, 2019-2030
        5.4.2 North America Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Cyclic Peptide Compounds Sales Value, 2019-2030
        5.5.2 Europe Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Cyclic Peptide Compounds Sales Value, 2019-2030
        5.6.2 Asia Pacific Cyclic Peptide Compounds Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Cyclic Peptide Compounds Sales Value, 2019-2030
        5.7.2 South America Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Cyclic Peptide Compounds Sales Value, 2019-2030
        5.8.2 Middle East & Africa Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cyclic Peptide Compounds Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Cyclic Peptide Compounds Sales Value
        6.2.1 Key Countries/Regions Cyclic Peptide Compounds Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Cyclic Peptide Compounds Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Cyclic Peptide Compounds Sales Value, 2019-2030
        6.3.2 United States Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Cyclic Peptide Compounds Sales Value, 2019-2030
        6.4.2 Europe Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Cyclic Peptide Compounds Sales Value, 2019-2030
        6.5.2 China Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Cyclic Peptide Compounds Sales Value, 2019-2030
        6.6.2 Japan Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Cyclic Peptide Compounds Sales Value, 2019-2030
        6.7.2 South Korea Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cyclic Peptide Compounds Sales Value, 2019-2030
        6.8.2 Southeast Asia Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Cyclic Peptide Compounds Sales Value, 2019-2030
        6.9.2 India Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Cyclic Peptide Compounds Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bicycle Therapeutics
        7.1.1 Bicycle Therapeutics Company Information
        7.1.2 Bicycle Therapeutics Introduction and Business Overview
        7.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Bicycle Therapeutics Cyclic Peptide Compounds Product Offerings
        7.1.5 Bicycle Therapeutics Recent Development
    7.2 Apellis Pharmaceuticals
        7.2.1 Apellis Pharmaceuticals Company Information
        7.2.2 Apellis Pharmaceuticals Introduction and Business Overview
        7.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Offerings
        7.2.5 Apellis Pharmaceuticals Recent Development
    7.3 Merck
        7.3.1 Merck Company Information
        7.3.2 Merck Introduction and Business Overview
        7.3.3 Merck Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Merck Cyclic Peptide Compounds Product Offerings
        7.3.5 Merck Recent Development
    7.4 Bachem
        7.4.1 Bachem Company Information
        7.4.2 Bachem Introduction and Business Overview
        7.4.3 Bachem Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Bachem Cyclic Peptide Compounds Product Offerings
        7.4.5 Bachem Recent Development
    7.5 Novartis
        7.5.1 Novartis Company Information
        7.5.2 Novartis Introduction and Business Overview
        7.5.3 Novartis Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 Novartis Cyclic Peptide Compounds Product Offerings
        7.5.5 Novartis Recent Development
    7.6 Roche (Chugai Pharmabody Research)
        7.6.1 Roche (Chugai Pharmabody Research) Company Information
        7.6.2 Roche (Chugai Pharmabody Research) Introduction and Business Overview
        7.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Offerings
        7.6.5 Roche (Chugai Pharmabody Research) Recent Development
    7.7 Biopharma PEG Scientific
        7.7.1 Biopharma PEG Scientific Company Information
        7.7.2 Biopharma PEG Scientific Introduction and Business Overview
        7.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.7.4 Biopharma PEG Scientific Cyclic Peptide Compounds Product Offerings
        7.7.5 Biopharma PEG Scientific Recent Development
    7.8 Pfizer
        7.8.1 Pfizer Company Information
        7.8.2 Pfizer Introduction and Business Overview
        7.8.3 Pfizer Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.8.4 Pfizer Cyclic Peptide Compounds Product Offerings
        7.8.5 Pfizer Recent Development
    7.9 AstraZeneca
        7.9.1 AstraZeneca Company Information
        7.9.2 AstraZeneca Introduction and Business Overview
        7.9.3 AstraZeneca Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.9.4 AstraZeneca Cyclic Peptide Compounds Product Offerings
        7.9.5 AstraZeneca Recent Development
    7.10 Eli Lilly
        7.10.1 Eli Lilly Company Information
        7.10.2 Eli Lilly Introduction and Business Overview
        7.10.3 Eli Lilly Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.10.4 Eli Lilly Cyclic Peptide Compounds Product Offerings
        7.10.5 Eli Lilly Recent Development
    7.11 GenScript Biotech
        7.11.1 GenScript Biotech Company Information
        7.11.2 GenScript Biotech Introduction and Business Overview
        7.11.3 GenScript Biotech Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
        7.11.4 GenScript Biotech Cyclic Peptide Compounds Product Offerings
        7.11.5 GenScript Biotech Recent Development

 8 Industry Chain Analysis
    8.1 Cyclic Peptide Compounds Industrial Chain
    8.2 Cyclic Peptide Compounds Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cyclic Peptide Compounds Sales Model
        8.5.2 Sales Channel
        8.5.3 Cyclic Peptide Compounds Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

List of Tables
 Table 1. Cyclic Peptide Compounds Market Trends
 Table 2. Cyclic Peptide Compounds Market Drivers & Opportunity
 Table 3. Cyclic Peptide Compounds Market Challenges
 Table 4. Cyclic Peptide Compounds Market Restraints
 Table 5. Global Cyclic Peptide Compounds Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Cyclic Peptide Compounds Revenue Market Share by Company (2019-2024)
 Table 7. Global Cyclic Peptide Compounds Sales Volume by Company (2019-2024) & (Tons)
 Table 8. Global Cyclic Peptide Compounds Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market Cyclic Peptide Compounds Price by Company (2019-2024) & (US$/kg)
 Table 10. Key Manufacturers Cyclic Peptide Compounds Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Cyclic Peptide Compounds Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Cyclic Peptide Compounds
 Table 13. Global Cyclic Peptide Compounds Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptide Compounds as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cyclic Peptide Compounds Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Cyclic Peptide Compounds Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global Cyclic Peptide Compounds Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global Cyclic Peptide Compounds Sales Market Share in Value by Type (2019-2024)
 Table 20. Global Cyclic Peptide Compounds Sales Market Share in Value by Type (2025-2030)
 Table 21. Global Cyclic Peptide Compounds Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
 Table 22. Global Cyclic Peptide Compounds Sales Volume by Type (2019-2024) & (Tons)
 Table 23. Global Cyclic Peptide Compounds Sales Volume by Type (2025-2030) & (Tons)
 Table 24. Global Cyclic Peptide Compounds Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global Cyclic Peptide Compounds Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global Cyclic Peptide Compounds Price by Type (2019-2024) & (US$/kg)
 Table 27. Global Cyclic Peptide Compounds Price by Type (2025-2030) & (US$/kg)
 Table 28. Global Cyclic Peptide Compounds Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global Cyclic Peptide Compounds Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global Cyclic Peptide Compounds Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global Cyclic Peptide Compounds Sales Market Share in Value by Application (2019-2024)
 Table 32. Global Cyclic Peptide Compounds Sales Market Share in Value by Application (2025-2030)
 Table 33. Global Cyclic Peptide Compounds Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
 Table 34. Global Cyclic Peptide Compounds Sales Volume by Application (2019-2024) & (Tons)
 Table 35. Global Cyclic Peptide Compounds Sales Volume by Application (2025-2030) & (Tons)
 Table 36. Global Cyclic Peptide Compounds Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global Cyclic Peptide Compounds Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global Cyclic Peptide Compounds Price by Application (2019-2024) & (US$/kg)
 Table 39. Global Cyclic Peptide Compounds Price by Application (2025-2030) & (US$/kg)
 Table 40. Global Cyclic Peptide Compounds Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global Cyclic Peptide Compounds Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global Cyclic Peptide Compounds Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global Cyclic Peptide Compounds Sales Value by Region (2019-2024) & (%)
 Table 44. Global Cyclic Peptide Compounds Sales Value by Region (2025-2030) & (%)
 Table 45. Global Cyclic Peptide Compounds Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
 Table 46. Global Cyclic Peptide Compounds Sales Volume by Region (2019-2024) & (Tons)
 Table 47. Global Cyclic Peptide Compounds Sales Volume by Region (2025-2030) & (Tons)
 Table 48. Global Cyclic Peptide Compounds Sales Volume by Region (2019-2024) & (%)
 Table 49. Global Cyclic Peptide Compounds Sales Volume by Region (2025-2030) & (%)
 Table 50. Global Cyclic Peptide Compounds Average Price by Region (2019-2024) & (US$/kg)
 Table 51. Global Cyclic Peptide Compounds Average Price by Region (2025-2030) & (US$/kg)
 Table 52. Key Countries/Regions Cyclic Peptide Compounds Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions Cyclic Peptide Compounds Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions Cyclic Peptide Compounds Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions Cyclic Peptide Compounds Sales Volume, (2019-2024) & (Tons)
 Table 56. Key Countries/Regions Cyclic Peptide Compounds Sales Volume, (2025-2030) & (Tons)
 Table 57. Bicycle Therapeutics Company Information
 Table 58. Bicycle Therapeutics Introduction and Business Overview
 Table 59. Bicycle Therapeutics Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 60. Bicycle Therapeutics Cyclic Peptide Compounds Product Offerings
 Table 61. Bicycle Therapeutics Recent Development
 Table 62. Apellis Pharmaceuticals Company Information
 Table 63. Apellis Pharmaceuticals Introduction and Business Overview
 Table 64. Apellis Pharmaceuticals Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 65. Apellis Pharmaceuticals Cyclic Peptide Compounds Product Offerings
 Table 66. Apellis Pharmaceuticals Recent Development
 Table 67. Merck Company Information
 Table 68. Merck Introduction and Business Overview
 Table 69. Merck Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 70. Merck Cyclic Peptide Compounds Product Offerings
 Table 71. Merck Recent Development
 Table 72. Bachem Company Information
 Table 73. Bachem Introduction and Business Overview
 Table 74. Bachem Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 75. Bachem Cyclic Peptide Compounds Product Offerings
 Table 76. Bachem Recent Development
 Table 77. Novartis Company Information
 Table 78. Novartis Introduction and Business Overview
 Table 79. Novartis Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 80. Novartis Cyclic Peptide Compounds Product Offerings
 Table 81. Novartis Recent Development
 Table 82. Roche (Chugai Pharmabody Research) Company Information
 Table 83. Roche (Chugai Pharmabody Research) Introduction and Business Overview
 Table 84. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 85. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Offerings
 Table 86. Roche (Chugai Pharmabody Research) Recent Development
 Table 87. Biopharma PEG Scientific Company Information
 Table 88. Biopharma PEG Scientific Introduction and Business Overview
 Table 89. Biopharma PEG Scientific Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 90. Biopharma PEG Scientific Cyclic Peptide Compounds Product Offerings
 Table 91. Biopharma PEG Scientific Recent Development
 Table 92. Pfizer Company Information
 Table 93. Pfizer Introduction and Business Overview
 Table 94. Pfizer Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 95. Pfizer Cyclic Peptide Compounds Product Offerings
 Table 96. Pfizer Recent Development
 Table 97. AstraZeneca Company Information
 Table 98. AstraZeneca Introduction and Business Overview
 Table 99. AstraZeneca Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 100. AstraZeneca Cyclic Peptide Compounds Product Offerings
 Table 101. AstraZeneca Recent Development
 Table 102. Eli Lilly Company Information
 Table 103. Eli Lilly Introduction and Business Overview
 Table 104. Eli Lilly Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 105. Eli Lilly Cyclic Peptide Compounds Product Offerings
 Table 106. Eli Lilly Recent Development
 Table 107. GenScript Biotech Company Information
 Table 108. GenScript Biotech Introduction and Business Overview
 Table 109. GenScript Biotech Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 110. GenScript Biotech Cyclic Peptide Compounds Product Offerings
 Table 111. GenScript Biotech Recent Development
 Table 112. Key Raw Materials Lists
 Table 113. Raw Materials Key Suppliers Lists
 Table 114. Cyclic Peptide Compounds Downstream Customers
 Table 115. Cyclic Peptide Compounds Distributors List
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cyclic Peptide Compounds Product Picture
 Figure 2. Global Cyclic Peptide Compounds Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Cyclic Peptide Compounds Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global Cyclic Peptide Compounds Sales Volume (2019-2030) & (Tons)
 Figure 5. Global Cyclic Peptide Compounds Sales Price (2019-2030) & (US$/kg)
 Figure 6. Cyclic Peptide Compounds Report Years Considered
 Figure 7. Global Cyclic Peptide Compounds Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global Cyclic Peptide Compounds Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cyclic Peptide Compounds Revenue in 2023
 Figure 10. Cyclic Peptide Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. Natural Cyclic Peptide Picture
 Figure 12. Synthetic Cyclic Peptide Picture
 Figure 13. Global Cyclic Peptide Compounds Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 14. Global Cyclic Peptide Compounds Sales Value Market Share by Type, 2023 & 2030
 Figure 15. Global Cyclic Peptide Compounds Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
 Figure 16. Global Cyclic Peptide Compounds Sales Volume Market Share by Type, 2023 & 2030
 Figure 17. Global Cyclic Peptide Compounds Price by Type (2019-2030) & (US$/kg)
 Figure 18. Product Picture of Biopharmaceutical
 Figure 19. Product Picture of Environmental Protection
 Figure 20. Product Picture of Scientific Research
 Figure 21. Product Picture of Others
 Figure 22. Global Cyclic Peptide Compounds Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 23. Global Cyclic Peptide Compounds Sales Value Market Share by Application, 2023 & 2030
 Figure 24. Global Cyclic Peptide Compounds Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
 Figure 25. Global Cyclic Peptide Compounds Sales Volume Market Share by Application, 2023 & 2030
 Figure 26. Global Cyclic Peptide Compounds Price by Application (2019-2030) & (US$/kg)
 Figure 27. North America Cyclic Peptide Compounds Sales Value (2019-2030) & (US$ Million)
 Figure 28. North America Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
 Figure 29. Europe Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 30. Europe Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
 Figure 31. Asia Pacific Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Cyclic Peptide Compounds Sales Value by Region (%), 2023 VS 2030
 Figure 33. South America Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 34. South America Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
 Figure 35. Middle East & Africa Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 36. Middle East & Africa Cyclic Peptide Compounds Sales Value by Country (%), 2023 VS 2030
 Figure 37. Key Countries/Regions Cyclic Peptide Compounds Sales Value (%), (2019-2030)
 Figure 38. Key Countries/Regions Cyclic Peptide Compounds Sales Volume (%), (2019-2030)
 Figure 39. United States Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 40. United States Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 41. United States Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 42. Europe Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 43. Europe Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 44. Europe Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 45. China Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 46. China Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 47. China Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 48. Japan Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 49. Japan Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 50. Japan Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 51. South Korea Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 52. South Korea Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 53. South Korea Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 54. Southeast Asia Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 55. Southeast Asia Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 56. Southeast Asia Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 57. India Cyclic Peptide Compounds Sales Value, (2019-2030) & (US$ Million)
 Figure 58. India Cyclic Peptide Compounds Sales Value by Type (%), 2023 VS 2030
 Figure 59. India Cyclic Peptide Compounds Sales Value by Application (%), 2023 VS 2030
 Figure 60. Cyclic Peptide Compounds Industrial Chain
 Figure 61. Cyclic Peptide Compounds Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed

The global market for Cyclic Peptide Compounds was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cyclic Peptide Compounds was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cyclic Peptide Compounds include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Cyclic Peptide Compounds, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cyclic Peptide Compounds by region & country, by Type, and by Application.

The Cyclic Peptide Compounds market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclic Peptide Compounds.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cyclic Peptide Compounds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cyclic Peptide Compounds in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.